• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

瓣膜病的综合护理管理

Comprehensive Nursing Management for Valvular Disease.

作者信息

Lee Susan

机构信息

School of Nursing, Louisiana State University Health, 1900 Gravier Street, Room 328, New Orleans, LA 70112, USA.

出版信息

Crit Care Nurs Clin North Am. 2019 Mar;31(1):31-38. doi: 10.1016/j.cnc.2018.11.002. Epub 2018 Dec 22.

DOI:10.1016/j.cnc.2018.11.002
PMID:30736933
Abstract

Valvular heart dysfunction (VHD) affects up to 7% of adults up to age 44 year, whereas up to 13% of individuals older than 75 years are affected. The broad term of valvular heart disease includes dysfunction of one or more of the 4 heart valves, including the pulmonary valve, tricuspid valve, mitral valve, or aortic valve. Specifically the more frequent anomalies, implication, assessment, and treatment that will be described more extensively include aortic regurgitation, aortic stenosis, mitral regurgitation, or tricuspid regurgitation. The most prevalent cause of valvular heart disease stems from calcification and stiffening of the valve leaflets contributing to stenosis.

摘要

瓣膜性心脏功能障碍(VHD)在44岁及以下的成年人中影响比例高达7%,而在75岁以上的人群中,受影响比例高达13%。瓣膜性心脏病这一宽泛术语包括四个心脏瓣膜中一个或多个瓣膜的功能障碍,这四个瓣膜分别为肺动脉瓣、三尖瓣、二尖瓣或主动脉瓣。具体而言,将更详细描述的更常见的异常、影响、评估和治疗包括主动脉瓣反流、主动脉瓣狭窄、二尖瓣反流或三尖瓣反流。瓣膜性心脏病最常见的病因源于瓣膜小叶的钙化和硬化,进而导致狭窄。

相似文献

1
Comprehensive Nursing Management for Valvular Disease.瓣膜病的综合护理管理
Crit Care Nurs Clin North Am. 2019 Mar;31(1):31-38. doi: 10.1016/j.cnc.2018.11.002. Epub 2018 Dec 22.
2
Identifying the Severity of Heart Valve Stenosis and Regurgitation Among a Diverse Population Within an Integrated Health Care System: Natural Language Processing Approach.在综合性医疗保健系统中识别不同人群中心脏瓣膜狭窄和反流的严重程度:自然语言处理方法。
JMIR Cardio. 2024 Sep 30;8:e60503. doi: 10.2196/60503.
3
Tricuspid regurgitation: Frequency, clinical presentation, management and outcome among patients with severe left-sided valvular heart disease in Europe. Insights from the ESC-EORP Valvular Heart Disease II survey.三尖瓣反流:欧洲重度左侧瓣膜性心脏病患者的发生率、临床表现、管理及预后。欧洲心脏病学会-欧洲注册瓣膜性心脏病II调查的见解
Eur J Heart Fail. 2024 Apr;26(4):994-1003. doi: 10.1002/ejhf.3157. Epub 2024 Feb 19.
4
[The best of valvular heart disease in 2006].[2006年心脏瓣膜病研究精粹]
Arch Mal Coeur Vaiss. 2007 Jan;100 Spec No 1:19-28.
5
Lipoprotein(a) is a risk factor for aortic and mitral valvular stenosis in peripheral arterial disease.脂蛋白(a)是外周动脉疾病主动脉瓣和二尖瓣狭窄的一个危险因素。
Eur Heart J Cardiovasc Imaging. 2016 May;17(5):492-7. doi: 10.1093/ehjci/jev338. Epub 2016 Jan 12.
6
[Clinical characteristics of patients with moderate or severe valvular heart disease].[中重度瓣膜性心脏病患者的临床特征]
Zhonghua Xin Xue Guan Bing Za Zhi. 2024 Oct 24;52(10):1200-1206. doi: 10.3760/cma.j.cn112148-20230816-00082.
7
Valvular Heart Disease in Adults: Management of Native Valve Disease.成人心脏瓣膜病:原发性瓣膜病的管理
FP Essent. 2017 Jun;457:17-22.
8
Valvular Heart Disease.心脏瓣膜病
Prim Care. 2018 Mar;45(1):81-94. doi: 10.1016/j.pop.2017.10.002. Epub 2017 Dec 27.
9
Morphologic features of the normal and abnormal mitral valve.正常和异常二尖瓣的形态学特征。
Am J Cardiol. 1983 Mar 15;51(6):1005-28. doi: 10.1016/s0002-9149(83)80181-7.
10
Trends and Disparities in Valvular Heart Disease Mortality in the United States From 1999 to 2020.1999 年至 2020 年美国瓣膜性心脏病死亡率的趋势和差异。
J Am Heart Assoc. 2024 Apr 16;13(8):e030895. doi: 10.1161/JAHA.123.030895. Epub 2024 Apr 8.

引用本文的文献

1
Treatment of Chronic Pulmonary Heart Disease with Traditional Chinese Medicine: A Protocol for the Development of a Core Outcome Set (COS-TCM-CPHD).中医治疗慢性肺源性心脏病:核心结局集(COS-TCM-CPHD)的制定方案
Evid Based Complement Alternat Med. 2021 Apr 12;2021:5559883. doi: 10.1155/2021/5559883. eCollection 2021.